Ken Van Weyenberg has been Head of Client Portfolio Management Fundamental Equity since 2025. Since joining Candriam in 2010, his previous roles have included Senior Client Portfolio Manager for Thematic Global Equity, Head of Client Portfolio Management for Private Clients & Asset Allocation, and Senior Investment Specialist in Private Clients & Asset Allocation.
Before joining the asset management industry, Ken spent three years in media and financial journalism at Kanaal Z/Canal Z and Moneytalk & Cash.
Ken holds a Bachelor’s in Journalism from Artevelde Hogeschool Gent, Belgium.
Discover the latest articles by Ken Van Weyenberg
Ken Van Weyenberg, Equities, ESG, SRI
The environmental transition has entered a new phase. What was once seen as a gradual, policy-led shift is unfolding as a faster, economically driven transformation. Technology, cost dynamics and rising physical risks are converging, turning environmental change into a central force redefining growth, capital allocation and corporate strategy.
Equities, Ken Van Weyenberg, Quentin Duquesne
Structural shift towards European autonomy gains momentum
Recent geopolitical tensions in the Middle East have triggered renewed energy and supply shocks in Europe, exposing the continent's reliance on external dependencies.
Research Paper, AI, Equities, Jean-Baptiste Sergeant, Johan Van der Biest, Ken Van Weyenberg
Disruptive technologies
The world of 2030 is already taking shape: AI assistants embedded in daily life, autonomous mobility, software-defined factories, digital twins, and smarter energy systems that optimise demand in real time.
Research Paper, Equities, Geopolitics, Infrastructure, Johan Van der Biest, Ken Van Weyenberg
Geopolitical fragmentation, investing in a multipolar world
Geopolitical Fragmentation | Europe’s Investment Moment | Candriam
Discover how Europe’s drive for strategic autonomy is reshaping global investing. Read Candriam’s latest research and explore our European Autonomy Fund.
Ken Van Weyenberg, Oncology, ESG, SRI, Healthcare
Why oncology remains a key investment opportunity
The investment landscape is marked by persistent macroeconomic uncertainties, uneven growth, and heightened geopolitical risks. Despite attractive earnings growth, healthcare has also been under pressure due to regulatory restructuring, drug pricing debates, budget constraints, and tariff concerns.